{"transactions":[{"id":1408655,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":81478,"kind":"person","name":"Kim Dong","position":1,"cik":"0001920163","reported_name":"Kim Dong","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-09-12T17:50:15.000Z","date":"2024-09-09","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted RSUs on September 7, 2023 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person was granted RSUs on September 7, 2023 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."}],"balance_after":5000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001437749-24-029036","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924029036/rdgdoc.xml","form_type":"4"}},{"id":1408654,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":81478,"kind":"person","name":"Kim Dong","position":1,"cik":"0001920163","reported_name":"Kim Dong","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-12T17:50:15.000Z","date":"2024-09-09","kind":"exercise","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":37753,"source":{"system":"sec-edgar","filing":"0001437749-24-029036","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924029036/rdgdoc.xml","form_type":"4"}},{"id":1649230,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":81478,"kind":"person","name":"Kim Dong","position":1,"cik":"0001920163","reported_name":"Kim Dong","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-02-12T22:47:51.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment corrects and restates the Amount of Securities Beneficially Owned Following Reported Transaction reported in the original Form 4 filed on February 2, 2024."}],"balance_after":35253,"source":{"system":"sec-edgar","filing":"0001437749-24-003794","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003794/rdgdoc.xml","form_type":"4/A","original_submission_date":"2024-02-02"}},{"id":1649229,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":81478,"kind":"person","name":"Kim Dong","position":1,"cik":"0001920163","reported_name":"Kim Dong","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-12T22:43:15.000Z","date":"2022-03-25","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This amendment corrects and restates the number of derivative securities acquired reported in the original Form 4 filed on March 29, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the stock option will vest on each of March 25, 2023, March 25, 2024 and March 25, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This amendment corrects and restates the expiration date reported in the original Form 4 filed on March 29, 2022."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"This amendment corrects and restates the amount of securities underlying derivative security reported in the original Form 4 filed on March 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This amendment corrects and restates the number of derivative securities beneficially owned following reported transaction reported in the original Form 4 filed on March 29, 2022."}],"balance_after":20000,"derivative":{"exercise_price":8.61,"expiration_date":"2032-03-25","underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-24-003792","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003792/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-03-29"}},{"id":1661718,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":81478,"kind":"person","name":"Kim Dong","position":1,"cik":"0001920163","reported_name":"Kim Dong","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-03T00:05:51.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027."}],"balance_after":12000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001437749-24-003014","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003014/rdgdoc.xml","form_type":"4"}},{"id":1661717,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":81478,"kind":"person","name":"Kim Dong","position":1,"cik":"0001920163","reported_name":"Kim Dong","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-03T00:05:51.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."}],"balance_after":6667,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001437749-24-003014","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003014/rdgdoc.xml","form_type":"4"}},{"id":1661716,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":81478,"kind":"person","name":"Kim Dong","position":1,"cik":"0001920163","reported_name":"Kim Dong","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-02-03T00:05:51.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":26585,"source":{"system":"sec-edgar","filing":"0001437749-24-003014","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003014/rdgdoc.xml","form_type":"4"}},{"id":1784650,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":81478,"kind":"person","name":"Kim Dong","position":1,"cik":"0001920163","reported_name":"Kim Dong","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-09-08T19:41:07.000Z","date":"2023-09-07","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026"}],"balance_after":7500,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001437749-23-025478","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923025478/rdgdoc.xml","form_type":"4"}},{"id":2036142,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":81478,"kind":"person","name":"Kim Dong","position":1,"cik":"0001920163","reported_name":"Kim Dong","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-02T18:05:44.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026."}],"balance_after":38000,"derivative":{"exercise_price":10.39,"expiration_date":"2033-01-31","underlying":"Ordinary Shares","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001437749-23-002340","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002340/rdgdoc.xml","form_type":"4"}},{"id":2036141,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":81478,"kind":"person","name":"Kim Dong","position":1,"cik":"0001920163","reported_name":"Kim Dong","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-02T18:05:44.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026."}],"balance_after":10000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-23-002340","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002340/rdgdoc.xml","form_type":"4"}},{"id":2315348,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":81478,"kind":"person","name":"Kim Dong","position":1,"cik":"0001920163","reported_name":"Kim Dong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-29T23:14:11.000Z","date":"2022-03-25","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the stock option will vest on each of March 25, 2023, March 25, 2024 and March 25, 2025."}],"balance_after":30000,"derivative":{"exercise_price":8.61,"expiration_date":"2032-03-24","underlying":"Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-021524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122021524/doc4.xml","form_type":"4"}}]}